TITLE

General considerations

PUB. DATE
September 2004
SOURCE
WHO Technical Report Series;2004, Issue 927, p66
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on polysaccharide vaccines for infections caused by Streptococcus pneumoniae, which are responsible for substantial morbidity and mortality, commonly on children and the elderly. Pneumociccus are classified based on chemical and serological distinct capsular polysaccharides. Polysaccharide vaccines are efficacious in children about 2 year of age but are not effective in younger children, while polysaccharide-protein conjugates have been demonstrated to be high in immunogenic in infants and to stimulate T-cell dependent immunity.
ACCESSION #
19839153

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics